









































Integrative Medicine Research 9 (2020) 100396
Contents lists available at ScienceDirect
Integrative  Medicine  Research
j o ur na l homepage: www.imr- journa l .com
etter  to  the  Editor
fficacy  of  abdominal  massage  with  mastic  gum  oil  on
astroesophageal  reflux  disease  symptoms  of  infant:  a  randomized
ontrolled  trial
oorieh  Mohammadi  Kenari a,b,  Mansureh  Akhavan a,b,c,∗, Mahnaz  Sadeghian d,
li  Ghobadi a,b, Shahrbanoo  Nakhaie e, Zahra  Rampisheh f,g, Nasrin  Khalessi h
Research Institute for Islamic and Complementary Medicine, Iran University of Medical Sciences, Tehran, Iran
School of Persian Medicine, Iran University of Medical Sciences, Tehran, Iran
Student Research Committee, Iran University of Medical Sciences, Tehran, Iran
Department of Pediatric Gastroenterology, Children Medical Center, Tehran University of Medical Sciences, Tehran, Iran
Associate professor Pediatric gastroenterologist, Iran University of Medical Sciences, Tehran, Iran
Preventive Medicine and Public Health Research Center, Iran University of Medical Sciences, Tehran, Iran
School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Department of Neonatology Ali Asghar Hospital, Iran University of Medical Sciences, Tehran, Iran
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 5 February 2020
eceived in revised form 18 February 2020
ccepted 19 February 2020
eywords:
astroesophageal reflux disease (GERD)
hildren, mastic gum
bdominal massage
Gastroesophageal reflux disease (GERD) still remains one of
he most common digestive disorder in neonates and infants.1,2
here are several non-pharmacological and pharmacological ther-
pies for GERD, however, most of them have limited efficacy, also
he long-term use of antacids and proton pump inhibitors have
ome side-effects including diarrhea, constipation, headache and
ausea.3 Consequently, there is a growing trend towards using
omplementary and alternative medicine worldwide. The aim of
his study was to the effect of mastic oil massage on treatment of
ERD in infants according to “The Canon of Medicine”.4
A total of 90 infant aged between one months to one year
ere included in the present study, diagnosis by a pediatric
astroenterologist according to GERD Symptom Questionnaire-
nfant (GSQ-I) during the last seven days.5,6 The participants
ere assigned into two groups of 45 patients using the block
andomization method. The experimental group received omepra-
ole (20 mg/12 h) and abdominal massage with mastic gum oil
every 12 h), while control group received omeprazole capsules
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2 weeks. The mother or nurse performed the abdominal massage
clockwise around the navel and stomach for 10 min, approximately
half an hour after the infant was fed (with milk or other food).
The outcome measures were regurgitation and irritability,
arching back and withdrawal, choking/gagging, and refusal to
feed. Data were collected using the Global Severity Question-
naire (GSQ), which assesses the severity and frequency of each
of the most common symptoms by age in the past 7 days,
before and 1, 2 and 4 weeks. Data were analyzed in SPSS
Statistics for Windows, version 16.0. Comparative tests such as
the repeated measures analysis and ANOVA were employed to
compare treatment outcomes in different weeks of interven-
tion.
Of fifty-four girls and thirty-six boys participated in this study
and seventy-three participants completed the study. Eight patients
in experimental group were discontinued the intervention because
of side effects including skin allergy (6), restlessness (1), and
diarrhea (1), while nine participants were excluded from analy-
sis not regular participation of abdominal massage. There were
no statistical differences between two  groups in age, gender, and
gastrointestinal complication in the mother (Supplement 1). In
.V.
2 H.M. Kenari, M. Akhavan, M. Sadeghian et al. / Integrative Medicine Research 9 (2020) 100396
Table 1
Change in CSS and ISS at Baseline, 1 and 2 Weeks after Treatment, 1 and 4 Weeks’ Follow-up.
Outcomes Baseline 1 week 2 weeks 1 week follow-up 4 weeks follow-up
CSS scores
Massage with oil 64.91 ± 42.10 33.38 ± 24.14 24.16 ± 23.10 32.54 ± 24.29 33.24 ± 24.10
Massage only 51.64 ± 28.25 41.78 ± 25.88 37.83 ± 26.56 38.50 ± 27.56 38.39 ± 27.73
Regurgitation (ISS)
Massage with oil 10.82 ± 11.24 5.97 ± 7.70 4.27 ± 7.22 5.86 ± 7.67 6.13 ± 7.63
Massage only 9.31 ± 11.80 7.24 ± 8.89 6.52 ± 8.89 6.77 ± 10.14 6.91 ± 10.56
Irritability/fussiness (ISS)
Massage with oil 11.44 ± 10.17 5.81 ± 4.41 4.89 ± 5.00 6.18 ± 5.03 5.94 ± 5.06
Massage only 11.66 ± 1.21 8.56 ± 9.28 8.13 ± 9.52 8.58 ± 10.10 8.52 ± 10.08
Arching back (ISS)
Massage with oil 14.35 ± 12.45 6.91 ± 6.71 4.78 ± 6.09 6.48 ± 6.68 6.51 ± 6.66
Massage only 10.00 ± 8.38 8.18 ± 7.60 0.61 ± 7.75 7.30 ± 6.72 7.25 ± 6.69
Choking/gaging (ISS)
Massage with oil 7.17 ± 8.04 3.78 ± 5.95 2.40 ± 4.59 3.67 ± 5.75 3.67 ± 5.75
Massage only 5.44 ± 6.07 4.45 ± 5.73 4.11 ± 5.80 4.16 ± 5.82 4.16 ± 5.82
Refusal to feed (ISS)
Massage with oil 11.35 ± 9.85 6.16 ± 6.27 4.40 ± 5.70 5.89 ± 6.27 6.18 ± 6.27
Massage only 7.57 ± 5.04 6.48 ± 4.59 6.11 ± 4.79 6.25 ± 4.86 6.11 ± 4.67
Episodes of hiccup (ISS)
























6. Deal L, Gold BD, Gremse DA, Winter HS, Peters SB, Fraga PD, et al. Age-specific
questionnaires distinguish GERD symptom frequency and severity in infants
and young children: development and initial validation. J Pediatr GastroenterolMassage only 7.66 ± 9.66 6.56 ± 10.09 
SS, Composite Symptom Score: the sum of the ISS values; ISS, Individual Symptom
oth groups, the mean composite symptoms score (CSS) decreased
ignificantly over time without a statistically significant differ-
nce between the groups (Table 1). In both groups, the individual
ymptom score (ISS) values decreased during the two  weeks of
reatment. ISS and CSS increased in the first and fourth weeks of
ollow-up but did not reach baseline levels. This can be due to the
hort course of treatment, and we need to increase the treatment
eriod.
In this study, ISS and CSS, as two measures of the reflux symp-
oms, reduced in the both groups after treatment, indicating that
he treatment was effective in both groups. However, there were
o significant difference between the two groups. The abdominal
assage with mastic oil may  not be more effective than massage
nly. However, more extensive studies with larger sample sizes and
onger treatment durations are recommended.
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